CSEA3 Annual Meeting

Programme

Back to Annual Congress 2026
We are pleased to present the official program of the CSEA3 Annual Meeting.
The schedule below outlines keynote lectures, thematic sessions, panel discussions, and networking opportunities designed to foster exchange of ideas and collaboration among participants.
TimeTitleSpeaker
10:00 – 11:30Drug allergytbd
10:00 – 11:30Severe asthmaAleksandra
Kucharczyk
(Poland)
10:00 – 11:30Allergen immunotherapy (AIT)tbd
11:30 – 13:00In vitro diagnosticsCarmen Bunu
(Romania)
11:30 – 13:00Food allergytbd
CSEA3 President Dejan Dokic
Congress Chair Marek Jutel
Congress Chair Ioana Agache
Congress Chair Radoslaw Gawlik
CHAIRS:
  • Radoslaw Gawlik (Poland)
  • Ioana Agache (Romania)
TimeTitleSpeaker
14:30-15:00New insights from asthmaLuiz Perez de Llano
(Spain)
15:00-15:30New insights from CRSAnju Peters
(US)
15:30-16:00New insights from ADEster del Duca
(Italy)
16:00-16:30Strategies for prevention and management of severe reactions in food allergyAnna
Nowak-Wegrzyn
(US)
16:30-17:00AIT versus biologicalsMarek Jutel
(Poland)
CHAIRS:
  • Luiz Perez de Llano (Spain)
TimeTitleSpeaker
17:30-18:00Mechanisms and biomarkersIoana Agache
(Romania)
18:00-18:30The impact of biologicalsCeleste Porsbjerg
(Denmark)
18:30-19:00Achieving long-term treatment benefits in severe asthma patientsPeter Howarth
(UK)
CHAIRS:
  • Magdalena Zemelka-Wiącek (Poland)
  • Carmen Bunu (Romania)
TimeTitleSpeaker
08:30 – 08:50Immunophenotyping of peripheral blood eosinophils in patients with asthmaJakub Novosad
(Czech Republic)
08:50 – 09:10Genetic markers of nasal polyposis and asthma: insights from Croatian patientsAnamarija Štajduha
(Croatia)
09:10 – 09:30The small airways syndromeMaciej Kupczyk
(Poland)
09:30 – 10:00The potential of skin tapesEster del Duca
(Italy)
CHAIRS:
  • Piotr Kuna (Poland)
TimeTitleSpeaker
10:30 – 10:36Evolution of biological treatment of asthmaPiotr Kuna (Poland)
10:36 – 10:54Depemokimab: Ultra Long-Acting biological for severe asthmaMaciej Kupczyk (Poland)
10:54 – 11:12Improving long-term biological treatment benefits in SA and CRSwNP – potential role of ULA depemokimabRadosław Gawlik (Poland)
11:12 – 11:30Persistence of the biological treatment effect in severe asthma – review of the published dataAlicja Majos (Poland) 
TimeTitleSpeaker
10:30 – 11:30Warsztaty (prowadzone w języku polskim): Immunoterapia w praktyce klinicznej – aktualna wiedza i interesujące przypadki klinicznePaweł Majak
(Poland)
CHAIRS:
  • Anna Nowak-Wegrzyn (US)
  • Mira Pevec (Croatia)
TimeTitleSpeaker
11:30 – 12:00Efficacy and safety of epicutaneous immunotherapy in children with peanut allergySharon Chinthrajah
(US)
12:00 -12:30Point-of-care blood eosinophils to predict preschool wheeze attacksSejal Saglani
(UK)
12:30-12:45Clinical manifestations of atopy in childrenDejan Djokić
(North Macedonia)
12:45-13:00Early presentation of hereditary angioedema symptoms in a 2-year-old boyJurate
Staikuniene-Kozonis
(Lithuania)
CHAIRS:
  • Tonya Winders (US)
  • tbd
TimeTitleSpeaker
14:00 – 14:30Climate change and aeroallergensAthanasios Damialis
(Greece)
14:30 – 15:00Nature-based solutionsTari Haahtela
(Finland)
15:00 – 15:30Environmental endotypesIoana Agache
(Romania)
TimeTitleSpeaker
14:00-15:00(prowadzone w języku polskim): Immunoterapia alergenowa (AIT) w niejednoznacznych przypadkach klinicznych – aspekty diagnostyczno-terapeutyczneMarek Jutel
(Poland)

Marita Nittner-Marszalska
(Poland)
CHAIRS:
  • Laura Malinauskienė (Lithuania)
  • tbd
TimeTitleSpeaker
16:00 – 16:20Experiences with an ultra-rush protocol for the initiation of hymenoptera venom immunotherapy using depot preparationsTomáš Balner
(Czech Republic)
16:20 – 16:40Venom allergy – diagnosis and treatmenttbd
16:40 – 17:00Status of AIT in Central and Eastern Europe – results of the CSEA3 surveyMagdalena Zemelka-Wiacek
(Poland)
17:00 – 17:30New AIT GuidelinesMarek Jutel
(Poland)
4 oral presentations by young investigators/PhD students – 10 minutes each with 5 minutes discussion
CHAIRS:
  • tbd
TimeTitleSpeaker
08:30 – 08:50Assessment of rhinitis using the exposure chamberMagdalena
Zemelka-Wiacek
(Poland)
08:50 – 09:20Molecular allergology in daily practiceJoana Vitte
(Romania)
09:20 – 09:50Ensuring the quality of diagnostic testsVera Mahler
(Germany)
09:50 – 10:15Novel techniques for skin testingSven Seys
(Belgium)
10:15 – 10:30Diagnosing contact allergyLaura Malinauskiene
(Lithuania)
CHAIRS:
  • Tomáš Balner (Czech Republic)
  • tbd
TimeTitleSpeaker
11:00 – 11:30Co-creation of the management planTonya Winders
(US)
11:30 – 11:55Biological treatment of chronic rhinosinusitis with polyps -real-life experienceRadoslaw Gawlik
(Poland)
11:55 – 12:20Asthma managementMarcin Moniuszko
(Poland)
12:20 – 12:45Drug and food allergyIwona
Poziomkowska-Gęsicka
(Poland)
At the end of the congress, the key points will be summarized by Marek Jutel and Ioana Agache.